Thursday, November 16, 2006: 12:30 PM-3:00 PM | |||
Yosemite A (Hilton San Francisco) | |||
#543 - Drug Delivery (I) (15D05) | |||
This session highlights recent research efforts in the broad area of design, characterization (in vitro and in vivo), and development of drug delivery systems with multi-functional properties for targeted and sustained drug delivery. Topics of interest include, but are not limited to: Effects of chemical structure and/or physical properties of drug delivery systems on loading efficiency and release kinetics; functionalizing drug carriers with moieties for specific targeting; blood circulation time and biodistribution of drug-carrier complexes after systemic injection; in vitro and in vivo studies of cellular uptake. | |||
Chair: | Efrosini Kokkoli | ||
CoChair: | Stavroula Sofou | ||
12:30 PM | 543a | Design of Targeted Nanocarriers for Optimal Drug Delivery to Stressed Endothelium: a Multiscale Modeling Approach Joshua Weinstein, Neeraj Agarwal, Ravi Radhakrishnan | |
12:50 PM | 543b | Comparative Analysis of the Uptake and Intracellular Fate of Nanoparticles in Different Epithelial Cell Types Malgorzata S. Cartiera, K. M. Johnson, V. Rajendran, M. J. Caplan, W. Mark Saltzman | |
1:10 PM | 543c | Efficient Sirna Delivery with Acetylated Polyethylenimine Lily Wong, Daniel W. Pack | |
1:30 PM | 543d | Biodegradable Spray Dried Microspheres and Discs Delivering Paclitaxel and Etanidazole for the Treatment of Giloma: an in Vivo Subcutaneous Study Benjamin Y. S. Ong, Pavan Kumar Naraharisetti, Jingwei Xie, Chi-Hwa Wang, Nick Sahinidis | |
1:50 PM | Break | ||
2:00 PM | 543e | Coated Microneedles for Transdermal Drug Delivery Harvinder S. Gill, Mark R. Prausnitz | |
2:20 PM | 543f | A Biodegradable Fiber for Controlled Delivery of Therapeutics to the Eye Brendan C. Mack, Kenneth W. Wright, Mark E. Davis | |
2:40 PM | 543g | Drug Elimination Kinetics in the Eye after Subconjunctival Delivery Stephanie H. Kim, Robert J. Lutz, Karl G. Csaky, Craig J. Galban, Nam Sun Wang |
See more of Food, Pharmaceutical & Bioengineering Division
See more of The 2006 Annual Meeting